Global Pets Infectious Disease Screening 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08248823

Publication Date:

August 23, 2024

Pages:

112

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Pets Infectious Disease Screening is important. Animal Care Clinic recommends an infectious disease screen for all dogs on an annual basis. This simple blood test checks for heartworm disease, Lyme Disease, Ehrlichiosis, and Anaplasmosis, all of which can be prevented or treated if caught early.
The global Pets Infectious Disease Screening market size is projected to grow from US$ 426.5 million in 2023 to US$ 563 million in 2030; it is expected to grow at a CAGR of 4.0% from 2024 to 2030.
The 鈥淧ets Infectious Disease Screening Industry Forecast鈥� looks at past sales and reviews total world Pets Infectious Disease Screening sales in 2023, providing a comprehensive analysis by region and market sector of projected Pets Infectious Disease Screening sales for 2024 through 2030. With Pets Infectious Disease Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pets Infectious Disease Screening industry.
This Insight Report provides a comprehensive analysis of the global Pets Infectious Disease Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pets Infectious Disease Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pets Infectious Disease Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pets Infectious Disease Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pets Infectious Disease Screening.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 333%.
This report presents a comprehensive overview, market shares, and growth opportunities of Pets Infectious Disease Screening market by product type, application, key players and key regions and countries.
Segmentation by type
Heartworm Disease
Lyme Disease
Ehrlichiosis
Others
Segmentation by application
Pet Cat
Pet Dog
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mars
CVS Group
MedVet
PetVet Care Centers
New Ruipeng Pet Healthcare Group
PetIQ, Inc.
Vetco
Aiken Veterinary Clinic
Dehart Veterinary Services
Beloved Pet Hospital
Vegreville Veterinary Clinic

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Pets Infectious Disease Screening 麻豆原创 Size 2019-2030
2.1.2 Pets Infectious Disease Screening 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pets Infectious Disease Screening Segment by Type
2.2.1 Heartworm Disease
2.2.2 Lyme Disease
2.2.3 Ehrlichiosis
2.2.4 Others
2.3 Pets Infectious Disease Screening 麻豆原创 Size by Type
2.3.1 Pets Infectious Disease Screening 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pets Infectious Disease Screening 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Pets Infectious Disease Screening Segment by Application
2.4.1 Pet Cat
2.4.2 Pet Dog
2.4.3 Other
2.5 Pets Infectious Disease Screening 麻豆原创 Size by Application
2.5.1 Pets Infectious Disease Screening 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pets Infectious Disease Screening 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Pets Infectious Disease Screening 麻豆原创 Size by Player
3.1 Pets Infectious Disease Screening 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Pets Infectious Disease Screening Revenue by Players (2019-2024)
3.1.2 Global Pets Infectious Disease Screening Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Pets Infectious Disease Screening Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pets Infectious Disease Screening by Regions
4.1 Pets Infectious Disease Screening 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Pets Infectious Disease Screening 麻豆原创 Size Growth (2019-2024)
4.3 APAC Pets Infectious Disease Screening 麻豆原创 Size Growth (2019-2024)
4.4 Europe Pets Infectious Disease Screening 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Pets Infectious Disease Screening 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Pets Infectious Disease Screening 麻豆原创 Size by Country (2019-2024)
5.2 Americas Pets Infectious Disease Screening 麻豆原创 Size by Type (2019-2024)
5.3 Americas Pets Infectious Disease Screening 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pets Infectious Disease Screening 麻豆原创 Size by Region (2019-2024)
6.2 APAC Pets Infectious Disease Screening 麻豆原创 Size by Type (2019-2024)
6.3 APAC Pets Infectious Disease Screening 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pets Infectious Disease Screening by Country (2019-2024)
7.2 Europe Pets Infectious Disease Screening 麻豆原创 Size by Type (2019-2024)
7.3 Europe Pets Infectious Disease Screening 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pets Infectious Disease Screening by Region (2019-2024)
8.2 Middle East & Africa Pets Infectious Disease Screening 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Pets Infectious Disease Screening 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Pets Infectious Disease Screening 麻豆原创 Forecast
10.1 Global Pets Infectious Disease Screening Forecast by Regions (2025-2030)
10.1.1 Global Pets Infectious Disease Screening Forecast by Regions (2025-2030)
10.1.2 Americas Pets Infectious Disease Screening Forecast
10.1.3 APAC Pets Infectious Disease Screening Forecast
10.1.4 Europe Pets Infectious Disease Screening Forecast
10.1.5 Middle East & Africa Pets Infectious Disease Screening Forecast
10.2 Americas Pets Infectious Disease Screening Forecast by Country (2025-2030)
10.2.1 United States Pets Infectious Disease Screening 麻豆原创 Forecast
10.2.2 Canada Pets Infectious Disease Screening 麻豆原创 Forecast
10.2.3 Mexico Pets Infectious Disease Screening 麻豆原创 Forecast
10.2.4 Brazil Pets Infectious Disease Screening 麻豆原创 Forecast
10.3 APAC Pets Infectious Disease Screening Forecast by Region (2025-2030)
10.3.1 China Pets Infectious Disease Screening 麻豆原创 Forecast
10.3.2 Japan Pets Infectious Disease Screening 麻豆原创 Forecast
10.3.3 Korea Pets Infectious Disease Screening 麻豆原创 Forecast
10.3.4 Southeast Asia Pets Infectious Disease Screening 麻豆原创 Forecast
10.3.5 India Pets Infectious Disease Screening 麻豆原创 Forecast
10.3.6 Australia Pets Infectious Disease Screening 麻豆原创 Forecast
10.4 Europe Pets Infectious Disease Screening Forecast by Country (2025-2030)
10.4.1 Germany Pets Infectious Disease Screening 麻豆原创 Forecast
10.4.2 France Pets Infectious Disease Screening 麻豆原创 Forecast
10.4.3 UK Pets Infectious Disease Screening 麻豆原创 Forecast
10.4.4 Italy Pets Infectious Disease Screening 麻豆原创 Forecast
10.4.5 Russia Pets Infectious Disease Screening 麻豆原创 Forecast
10.5 Middle East & Africa Pets Infectious Disease Screening Forecast by Region (2025-2030)
10.5.1 Egypt Pets Infectious Disease Screening 麻豆原创 Forecast
10.5.2 South Africa Pets Infectious Disease Screening 麻豆原创 Forecast
10.5.3 Israel Pets Infectious Disease Screening 麻豆原创 Forecast
10.5.4 Turkey Pets Infectious Disease Screening 麻豆原创 Forecast
10.5.5 GCC Countries Pets Infectious Disease Screening 麻豆原创 Forecast
10.6 Global Pets Infectious Disease Screening Forecast by Type (2025-2030)
10.7 Global Pets Infectious Disease Screening Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Mars
11.1.1 Mars Company Information
11.1.2 Mars Pets Infectious Disease Screening Product Offered
11.1.3 Mars Pets Infectious Disease Screening Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Mars Main Business Overview
11.1.5 Mars Latest Developments
11.2 CVS Group
11.2.1 CVS Group Company Information
11.2.2 CVS Group Pets Infectious Disease Screening Product Offered
11.2.3 CVS Group Pets Infectious Disease Screening Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 CVS Group Main Business Overview
11.2.5 CVS Group Latest Developments
11.3 MedVet
11.3.1 MedVet Company Information
11.3.2 MedVet Pets Infectious Disease Screening Product Offered
11.3.3 MedVet Pets Infectious Disease Screening Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 MedVet Main Business Overview
11.3.5 MedVet Latest Developments
11.4 PetVet Care Centers
11.4.1 PetVet Care Centers Company Information
11.4.2 PetVet Care Centers Pets Infectious Disease Screening Product Offered
11.4.3 PetVet Care Centers Pets Infectious Disease Screening Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 PetVet Care Centers Main Business Overview
11.4.5 PetVet Care Centers Latest Developments
11.5 New Ruipeng Pet Healthcare Group
11.5.1 New Ruipeng Pet Healthcare Group Company Information
11.5.2 New Ruipeng Pet Healthcare Group Pets Infectious Disease Screening Product Offered
11.5.3 New Ruipeng Pet Healthcare Group Pets Infectious Disease Screening Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 New Ruipeng Pet Healthcare Group Main Business Overview
11.5.5 New Ruipeng Pet Healthcare Group Latest Developments
11.6 PetIQ, Inc.
11.6.1 PetIQ, Inc. Company Information
11.6.2 PetIQ, Inc. Pets Infectious Disease Screening Product Offered
11.6.3 PetIQ, Inc. Pets Infectious Disease Screening Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 PetIQ, Inc. Main Business Overview
11.6.5 PetIQ, Inc. Latest Developments
11.7 Vetco
11.7.1 Vetco Company Information
11.7.2 Vetco Pets Infectious Disease Screening Product Offered
11.7.3 Vetco Pets Infectious Disease Screening Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Vetco Main Business Overview
11.7.5 Vetco Latest Developments
11.8 Aiken Veterinary Clinic
11.8.1 Aiken Veterinary Clinic Company Information
11.8.2 Aiken Veterinary Clinic Pets Infectious Disease Screening Product Offered
11.8.3 Aiken Veterinary Clinic Pets Infectious Disease Screening Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Aiken Veterinary Clinic Main Business Overview
11.8.5 Aiken Veterinary Clinic Latest Developments
11.9 Dehart Veterinary Services
11.9.1 Dehart Veterinary Services Company Information
11.9.2 Dehart Veterinary Services Pets Infectious Disease Screening Product Offered
11.9.3 Dehart Veterinary Services Pets Infectious Disease Screening Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Dehart Veterinary Services Main Business Overview
11.9.5 Dehart Veterinary Services Latest Developments
11.10 Beloved Pet Hospital
11.10.1 Beloved Pet Hospital Company Information
11.10.2 Beloved Pet Hospital Pets Infectious Disease Screening Product Offered
11.10.3 Beloved Pet Hospital Pets Infectious Disease Screening Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Beloved Pet Hospital Main Business Overview
11.10.5 Beloved Pet Hospital Latest Developments
11.11 Vegreville Veterinary Clinic
11.11.1 Vegreville Veterinary Clinic Company Information
11.11.2 Vegreville Veterinary Clinic Pets Infectious Disease Screening Product Offered
11.11.3 Vegreville Veterinary Clinic Pets Infectious Disease Screening Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Vegreville Veterinary Clinic Main Business Overview
11.11.5 Vegreville Veterinary Clinic Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.